HIF1α identified as key regulator that induces cancer-killing ability of hypoxic T cells, playing a role in ICB resistance.

In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has history on its side.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

it showed no inhibition of the anti-tumour effect of DDP. This may be because LIN itself has anti-tumour abilities and does not promote tumor growth. However, a synergistic inhibitory effect between ...

Effect of ethanolic extract of Morinda citrifolia L on B16-F10 cell growth inhibition B16-F10 cells at 80% confluence ... It has shown to inhibit the growth of tumor cells in experimental model ...

Tumor cells circulating in the blood are the germ cells of breast cancer metastases. They are very rare and have not been ...

By inhibiting the DNA polymerases, BKC enhances the endogenous RS in cancer cells, leading to increased DNA damage. IBC specifically inhibits CHK2 to prevent DNA repair. The combined use of BKC and ...

The altered stress hormone levels can enhance tumor growth, disrupt cell repair mechanisms, and even compromise the body’s ability to recognize and destroy cancer cells. As a result, the ...

In a comprehensive assessment of PD-1, ... Enzyme Promoting Tumor Growth and Spread in Pancreatic Cancer Identified Jan. 2, 2025 — An enzyme called MICAL2 promotes tumor growth and metastasis in ...

Unfortunately, solid tumors are still treated with limited efficacy. In many cases, solid tumors are not recognized by the immune system and progress throughout the body. Tumor growth unnoticed ... a ...